Revised SPCs: Latuda (lurasidone hydrochloride) film-coated tablets – all strengths

SPCs updated to include an extension in treatment of schizophrenia for adolescents aged 13 and over; and a safety update regarding risk of serotonin syndrome with concomitant administration of lurasidone and other serotonergic agents.

electronic Medicines compendium